These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

874 related items for PubMed ID: 17295334

  • 21. Short and long-term outcomes of two drug eluting stents in bifurcation lesions.
    Chen JL, Gao RL, Yang YJ, Qiao SB, Qin XW, Yao M, Xu B, Liu HB, Wu YJ, Yuan JQ, Chen J, Wu Y, Dai J.
    Chin Med J (Engl); 2007 Feb 05; 120(3):183-6. PubMed ID: 17355818
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Crush stenting in treating coronary bifurcate lesions: paclitaxel eluting stents versus sirolimus eluting stents.
    Chen SL, Zhang JJ, Ye F, Chen YD, Zhu ZS, Lin S, Tian NL, Liu ZZ, Fang WY, Sun XW, Hu DY, Kwan TW.
    Chin Med J (Engl); 2008 Mar 20; 121(6):528-33. PubMed ID: 18364140
    [Abstract] [Full Text] [Related]

  • 24. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
    Marzocchi A, Saia F, Piovaccari G, Manari A, Aurier E, Benassi A, Cremonesi A, Percoco G, Varani E, Magnavacchi P, Guastaroba P, Grilli R, Maresta A.
    Circulation; 2007 Jun 26; 115(25):3181-8. PubMed ID: 17562952
    [Abstract] [Full Text] [Related]

  • 25. Provisional TAP-stenting strategy to treat bifurcated lesions with drug-eluting stents: one-year clinical results of a prospective registry.
    Burzotta F, Sgueglia GA, Trani C, Talarico GP, Coroleu SF, Giubilato S, Niccoli G, Giammarinaro M, Porto I, Leone AM, Mongiardo R, Mazzari MA, Schiavoni G, Crea F.
    J Invasive Cardiol; 2009 Oct 26; 21(10):532-7. PubMed ID: 19805841
    [Abstract] [Full Text] [Related]

  • 26. Impact of angiographic and intravascular ultrasound features on clinical outcome after sirolimus-eluting stent implantation for de-novo lesions in nondiabetic and type 2 diabetic patients.
    Du R, Zhang RY, Zhu ZB, Zhang Q, Hu J, Yang ZK, Yan ZJ, Lv AK, Ding FH, Zhang JS, Shen WF.
    Coron Artery Dis; 2010 May 26; 21(3):175-81. PubMed ID: 20305549
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Short-term and long-term outcomes of treating bifurcation lesions with two drug eluting stent techniques].
    Chen JL, Gao RL, Yang YJ, Qiao SB, Qin XW, Yao M, Xu B, Liu HB, Wu YJ, Yuan JQ, Chen J, You SJ, Dai J.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Dec 26; 34(12):1089-92. PubMed ID: 17274897
    [Abstract] [Full Text] [Related]

  • 29. Unprotected left main disease managed with drug-eluting stents: long-term outcome of 100 patients with increased surgical risk.
    Wood FO, Saylors EK, Schneider JE, Jobe RL, Mann JT.
    Catheter Cardiovasc Interv; 2008 Mar 01; 71(4):533-8. PubMed ID: 18307224
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Unprotected left main coronary artery stenting with zotarolimus (Endeavor) drug-eluting stents: a single center retrospective experience.
    Simard T, Hibbert B, Chong AY, Ruchin P, Le May M, Labinaz M, Froeschl M, So D, Glover C, Marquis JF, O'Brien E.
    Catheter Cardiovasc Interv; 2012 Aug 01; 80(2):E15-22. PubMed ID: 21805580
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical and angiographic outcomes after placement of multiple overlapping drug-eluting stents in diffuse coronary lesions.
    Lee CW, Park KH, Kim YH, Hong MK, Kim JJ, Park SW, Park SJ.
    Am J Cardiol; 2006 Oct 01; 98(7):918-22. PubMed ID: 16996874
    [Abstract] [Full Text] [Related]

  • 34. Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study.
    Beijk MA, Klomp M, van Geloven N, Koch KT, Henriques JP, Baan J, Vis MM, Tijssen JG, Piek JJ, de Winter RJ.
    Catheter Cardiovasc Interv; 2011 Aug 01; 78(2):189-95. PubMed ID: 21542109
    [Abstract] [Full Text] [Related]

  • 35. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL, SPIRIT III Investigators.
    Circulation; 2009 Feb 10; 119(5):680-6. PubMed ID: 19171853
    [Abstract] [Full Text] [Related]

  • 36. Novel side branch ostial stent (BIGUARD): first-in-man study.
    Chen SL, Zhang JJ, Ye F.
    Chin Med J (Engl); 2009 Sep 20; 122(18):2092-6. PubMed ID: 19781290
    [Abstract] [Full Text] [Related]

  • 37. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
    Varani E, Balducelli M, Vecchi G, Aquilina M, Maresta A.
    J Cardiovasc Med (Hagerstown); 2007 Aug 20; 8(8):596-601. PubMed ID: 17667030
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of stenting for unprotected left main coronary artery disease in 297 patients.
    Han YL, Wang SL, Jin QM, Liu HW, Ma YY, Wang ZL, Wang DM, Luan B, Wang G.
    Chin Med J (Engl); 2006 Apr 05; 119(7):544-50. PubMed ID: 16620694
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.